-
Je něco špatně v tomto záznamu ?
Absence of intervening sequences and point mutations in the V domain within 23S rRNA in Campylobacter lari isolates
T. Nakajima, W. Ara, S. Kagawa, JE. Moore, K. Matsubara, M. Matsuda,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální léková rezistence MeSH
- bodová mutace * MeSH
- Campylobacter lari účinky léků genetika izolace a purifikace MeSH
- erythromycin farmakologie MeSH
- introny * MeSH
- kampylobakterové infekce mikrobiologie veterinární MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mikrobiologie životního prostředí MeSH
- molekulární sekvence - údaje MeSH
- RNA ribozomální 23S genetika MeSH
- sekvence nukleotidů MeSH
- sekvenční analýza DNA MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Asie MeSH
- Evropa MeSH
- Severní Amerika MeSH
Although the absence of intervening sequences (IVSs) within the 23S rRNA genes in Campylobacter lari isolates has been described, there are apparently no reports regarding correlations between the nucleotide sequences of 23S rRNA genes and erythromycin (Ery) susceptibility in C. lari isolates. Here, we determined the minimum inhibitory concentrations of 35 C. lari isolates [n = 19 for urease-positive thermophilic Campylobacter (UPTC); n = 16 urease-negative (UN) C. lari] obtained from Asia, Europe, and North America. We found that the 18 isolates were resistant to the Ery (defined as ≧8 μg/mL), and three isolates, UPTC A1, UPTC 92251, and UPTC 504, showed increased resistance (16 μg/mL). No correlations between the IVSs in the helix 45 region within the 23S rRNA gene sequences and Ery resistance were identified in the C. lari isolates examined. In addition, no point mutations occurred at any expected or putative position within the V domain in the isolates. In conclusion, antibiotic resistance against the macrolide erythromycin is mediated through an alternative pathway to that described above.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14056103
- 003
- CZ-PrNML
- 005
- 20170410131130.0
- 007
- ta
- 008
- 140415s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-013-0250-x $2 doi
- 035 __
- $a (PubMed)23595231
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nakajima, Takuya
- 245 10
- $a Absence of intervening sequences and point mutations in the V domain within 23S rRNA in Campylobacter lari isolates / $c T. Nakajima, W. Ara, S. Kagawa, JE. Moore, K. Matsubara, M. Matsuda,
- 520 9_
- $a Although the absence of intervening sequences (IVSs) within the 23S rRNA genes in Campylobacter lari isolates has been described, there are apparently no reports regarding correlations between the nucleotide sequences of 23S rRNA genes and erythromycin (Ery) susceptibility in C. lari isolates. Here, we determined the minimum inhibitory concentrations of 35 C. lari isolates [n = 19 for urease-positive thermophilic Campylobacter (UPTC); n = 16 urease-negative (UN) C. lari] obtained from Asia, Europe, and North America. We found that the 18 isolates were resistant to the Ery (defined as ≧8 μg/mL), and three isolates, UPTC A1, UPTC 92251, and UPTC 504, showed increased resistance (16 μg/mL). No correlations between the IVSs in the helix 45 region within the 23S rRNA gene sequences and Ery resistance were identified in the C. lari isolates examined. In addition, no point mutations occurred at any expected or putative position within the V domain in the isolates. In conclusion, antibiotic resistance against the macrolide erythromycin is mediated through an alternative pathway to that described above.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a kampylobakterové infekce $x mikrobiologie $x veterinární $7 D002169
- 650 _2
- $a Campylobacter lari $x účinky léků $x genetika $x izolace a purifikace $7 D044863
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a mikrobiologie životního prostředí $7 D004783
- 650 _2
- $a erythromycin $x farmakologie $7 D004917
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a introny $7 D007438
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 12
- $a bodová mutace $7 D017354
- 650 _2
- $a RNA ribozomální 23S $x genetika $7 D012338
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 651 _2
- $a Asie $7 D001208
- 651 _2
- $a Evropa $7 D005060
- 651 _2
- $a Severní Amerika $7 D009656
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ara, Wakana $u - $7 gn_A_00007911
- 700 1_
- $a Kagawa, Shizuko $u -
- 700 1_
- $a Moore, John E $u -
- 700 1_
- $a Matsubara, Keiko $u -
- 700 1_
- $a Matsuda, Motoo $u -
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 58, č. 6 (2013), s. 607-613
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23595231 $y Pubmed
- 910 __
- $a ABA008 $b online $c sign $y a $z 0
- 990 __
- $a 20140415 $b ABA008
- 991 __
- $a 20170410131428 $b ABA008
- 999 __
- $a ok $b bmc $g 1019758 $s 854696
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 58 $c 6 $d 607-613 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20140415